- CEO
- Helen Giza
- Full Time Employees
- 112,035
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- Else-KrOener Strasse 1 Bad Homburg Germany 61352
- IPO Date
- Feb 7, 2012
- Business
- Fresenius Medical Care AG & Co. KGaA operates as a premier global entity in the comprehensive management of kidney diseases. The company delivers vital dialysis care services and a broad spectrum of associated support to individuals across the world suffering from chronic kidney failure and acute kidney conditions. Its service offerings encompass in-center dialysis treatments provided through an extensive international network of approximately 3,700 outpatient clinics, alongside support for home dialysis, and specialized care rendered under contract to hospitals for both hospitalized patients and those requiring acute renal support. Beyond its care delivery, Fresenius Medical Care is a prominent developer, manufacturer, and distributor of a diverse array of dialysis products. This includes advanced hemodialysis machines, dialyzers, bloodlines, solutions, and concentrates, as well as peritoneal dialysis cyclers and related solutions. The company also produces renal pharmaceuticals and sophisticated systems for water treatment, alongside non-dialysis products such as therapeutic apheresis systems. These products are supplied directly to its own clinics, other dialysis providers, and hospitals. Reflecting a strategic evolution, the company unveiled its FME Reignite strategy in June 2025, which includes the introduction of Value-Based Care as a distinct operating segment. This segment focuses on enhancing patient outcomes and managing the full kidney care journey through holistic and outcome-driven care coordination programs. As of late 2024, the company was caring for over 299,000 patients globally. Fresenius Medical Care AG & Co. KGaA, established in 1996, maintains its corporate headquarters in Bad Homburg vor der Höhe, Germany.